Evidence map›Paper›PMID 36255706›Full record

ReviewMethods in molecular biology (Clifton, N.J.)2023

Establishing a Murine Model of the Hematopoietic Acute Radiation Syndrome.

P Artur Plett, Louis M Pelus, Christie M Orschell

Open access · greenAbstract readReview
In one paragraph

Review in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

P Artur PlettDepartment of Medicine/Hematology Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.
Louis M PelusDepartment of Microbiology & Immunology and Department of Medicine/Hematology Oncology, Indiana University School of Medicine, Indianapolis, IN, USA.
Christie M OrschellDepartment of Medicine/Hematology Oncology, Indiana University School of Medicine, Indianapolis, IN, USA. corschel@iu.edu.
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Tumor Microenvironment and Metastasis ProgramP30CA082709 · NCI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Sara K Quinney · 1999 to 2026
$59.3M
Project-005U54DK106846 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Reuben Kapur, Karen Elizabeth Pollok · 2015 to 2026
$9.7M
BASIC SCIENCE STUDIES ON GENE THERAPY OF BLOOD DISEASEST32HL007910 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Roland W. Herzog, Reuben Kapur · 1999 to 2026
$7.6M
Role of PGE2 and other eicosanoids in hematopoietic stem cell functionR01HL096305 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI PELUS, LOUIS M · 2010 to 2018
$3.5M
Long-Acting G-CSF Analog for Treating ARSR44AI084288 · NIAID · BOLDER BIOTECHNOLOGY, INC. · PI COX, GEORGE NORBERT · 2013 to 2015
$3.2M
Long-acting growth factors for treating the acute and long term effects of lethalU01AI107340 · NIAID · BOLDER BIOTECHNOLOGY, INC. · PI COX, GEORGE NORBERT, ORSCHELL, CHRISTIE M · 2013 to 2017
$2.9M
A megakaryocyte/PGE2/osteoblast triad in the normal and aged nicheR01AG046246 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI KACENA, MELISSA A, PELUS, LOUIS M · 2013 to 2017
$1.1M
NCI NIH HHS P30 CA082709NHLBI NIH HHS R01 HL096305NHLBI NIH HHS T32 HL007910NIAID NIH HHS HHSN266200500030CNIAID NIH HHS R44 AI084288NIAID NIH HHS U01 AI107340NIA NIH HHS R01 AG046246NIDDK NIH HHS U54 DK106846
6 · The paper itself

Abstract

The hematopoietic system is one of the most sensitive tissues to ionizing radiation, and radiation doses from 2 to 10 gray can result in death from bleeding and infection if left untreated. Reviewing the range of radiation doses reported in the literature that result in similar lethality highlights the need for a more consistent model that would allow a better comparison of the hematopoietic acute radiation syndrome (H-ARS) studies carried out in different laboratories. Developing a murine model of H-ARS to provide a platform suited for efficacy testing of medical countermeasures (MCM) against radiation should include a review of the Food and Drug Administration requirements outlined in the Animal Rule. The various aspects of a murine H-ARS model found to affect consistent performance will be described in this chapter including strain, sex, radiation type and dose, mouse restraint, and husbandry.

Indexed as

Acute Radiation SyndromeHematopoietic SystemAnimalsDisease Models, AnimalMiceHusbandryLethal irradiation modelMice

Identifiers

PMID36255706
PMCPMC11192174
OpenAlexW4306697311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.